Thermo Fisher acquires Sanofi’s steriles manufacturing site in US
The transaction between Thermo Fisher and Sanofi is scheduled for completion in Q2 2025, subject to standard closing conditions.

The transaction between Thermo Fisher and Sanofi is scheduled for completion in Q2 2025, subject to standard closing conditions.
A sales rep looking up a healthcare professional's (HCP) contact details finds three records, each with conflicting information. At the same time, leadership struggles to generate accurate global reports due...
The pharmaceutical industry continues to be a hotbed of patent innovation. Activity is driven by the evolution of treatment paradigms,...
AI in drug discovery: from hypothetical to reality
Lisata collaborates with GATC Health on drug development
Juvenescence enhances AI drug discovery with Ro5 acquisition
Pharma’s AI prospects get nudged into the future with EU’s AI act